There are seven manufacturers of Remediswear in the country.
Several manufacturers of Remedsvir, which are being used in the treatment of COVID-19, said they have started producing the drug to meet its growing demand across the country.
In view of the increasing demand for the drug due to the spike in COVID-19 cases, the center on Sunday prohibited Remedisvir injection and export of its active drug ingredients (APIs) until the situation improves in the country.
A spokesperson for Zydus Cadila stated, “The current spike in COVID-19 cases has led to greater demand for Remedisvir. We are currently producing Remedisvir at our three facilities. To meet the demand, we have expanded from the first 5 Has ramped up production. ” -6 lakh vials in a month, 10-12 lakh vials in a month, which we will increase to 20 lakh vials in a month. “The supply situation will become more stable in a few weeks, the company said.
Dr. Reddy’s laboratories said that every effort was being made to ensure that its remedieswire reached as many patients as possible in India.
“We are accelerating production and bringing to market a liquid product that is faster to manufacture and supply. We have also reduced our MRP by 50%, so that price does not hinder access, And to have more number of patients. Access it, “Dr Reddy said in a statement.
The company expects the market situation to improve in the next few weeks.
Dr. Reddy’s said, “We will continue in our effort to provide medicines wherever necessary, and whenever they are needed.”
Rakesh Bamzai, President – India, Emerging Asia and Access Markets and Commercial Expansion and Biosimilar – Emerging Markets, Viatris (formerly called Mylan), said: “We are committed to meeting patient needs in India and ensuring access to it. Lea is partnering closely with the government. Serious pharmaceutical firm Sun Pharmaceutical Industries said it is expanding capacity for Remedisvir to meet demand growth in partnership with Syngene.
“Sun Pharma has already increased production and is now manufacturing Remedisvir at two plants. To help boost our production, it was recently decided to add another manufacturing site. We are in a constant position Monitoring and are continuously working to ensure patients across India. A SunV spokesperson said that for COVID-19 drugs.
The spokesperson said that the company is manufacturing and distributing rendezvir in India.
Pharma firm Cipla has also said that it has increased the production of remedieswear significantly since the last wave of the epidemic.
“We have increased the production of Remedisvir by 2x since the last wave of the pandemic, to meet demand. Given the unprecedented demand for the drug, we have now increased our capabilities through our network.”
There are seven manufacturers of Remediswear in the country.
“They have an installed capacity of about 38.80 lakh units per month,” the Ministry of Health and Family Welfare said on Sunday.
The department of medicine has approached domestic manufacturers to increase production of the drug.
The center said on Tuesday that doctors should ensure the “rational and prudent” use of the antiviral drug Remedisvir, underlining that it is to be given only to serious COVID-19 patients in hospitals and its use in home settings Not to be done.
.
Leave a Reply